Akarna Therapeutics Ltd acquired by Allergan plc
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St futures flat after tech rout; Iran tensions, retail earnings in focus
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Target raises full-year sales forecast amid ongoing turnaround drive
- Global bond rout pauses as sovereign yields back off multi-decade highs
- Lowe's slashes full-year sales outlook amid DIY spending pressure
- Tech selloff weighs down Wall Street as bond yields climb
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Francisco Partners to acquire Weave Communications for $650M
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Goldman Sachs to acquire real estate company LCN for up to $410M
Allergan (AGN) is on A Major Buying Spree... And It's Just Getting Started
September 20, 2016 4:46 PM EDTAllergan (NYSE: AGN) is wasting little time spending the $29 billion in net cash proceeds it received from the generics sale to Teva. The company has announced four deals since the start of September, including two in the last 12 hours:
09/06 - Allergan plc (NYSE: AGN) agreed to acquire RetroSense Therapeutics LLC, a private, clinical-stage biotechnology company focused on novel gene therapy approaches to restore... More